03737nam a22004215i 4500001001800000003000900018005001700027007001500044008004100059020003700100024003500137050001200172072001600184072002300200072001500223100008600238245010100324250001800425264006900443300005300512336002600565337002600591338003600617347002400653505157400677520075302251650002603004650002603030710003403056773002603090776003603116776003603152776003603188856004603224912001403270912001403284999001703298978-3-031-58799-3DE-He21320251030112900.0cr nn 008mamaa240820s2024    sz |    s    |||| 0|eng d  a97830315879939978-3-031-58799-37 a10.1007/978-3-031-58799-32doi 4aRE1-994 7aMJQ2bicssc 7aMED0630002bisacsh 7aMJQ2thema1 aWeiss, Jeffrey N.eauthor.4aut4http://id.loc.gov/vocabulary/relators/aut97986210aClinical Trials in Retinitis Pigmentosa Treatmenth[electronic resource] /cby Jeffrey N. Weiss.  a1st ed. 2024. 1aCham :bSpringer Nature Switzerland :bImprint: Springer,c2024.  aXII, 286 p. 4 illus. in color.bonline resource.  atextbtxt2rdacontent  acomputerbc2rdamedia  aonline resourcebcr2rdacarrier  atext filebPDF2rda0 aPart 1: Introduction -- Chapter 1. Introduction to Retinitis Pigmentosa -- Chapter 2. Treatments -- Chapter 3. Notes -- Part 2: Completed Clinical Trials -- Chapter 4. United States -- Chapter 5. Brazil -- Chapter 6. Turkey -- Part 3: Active, Recruiting Clinical Trials -- Chapter 7. United States -- Chapter 8. Latin America -- Chapter 9. Turkey -- Part 4: Not Yet Recruiting Clinical Trials -- Chapter 10. Indonesia -- Part 5: Active, Not Recruiting -- Chapter 11. United States -- Chapter 12. France -- Part 6: Enrolling by Invitation -- Chapter 13. United States -- Chapter 14. Indonesia -- Part 7: Gene Therapy Studies -- Chapter 15. United States/Europe -- Chapter 16. India -- Chapter 17. Saudi Arabia -- Part 8: Active, Recruiting Gene Therapy Studies -- Chapter 18. United States -- Chapter 19. China -- Part 9: Active, Not Recruiting Gene Therapy Studies -- Chapter 20. United States -- Chapter 21. Germany -- Chapter 22. Sweden -- Part 10: Enrolling by Invitation Gene Therapy Studies -- Chapter 23. Americas/Europe -- Chapter 24. India -- Part 11: Optogenetics -- Chapter 25. Active Trials in United States -- Part 12: Other Treatments -- Chapter 26. Completed Trials in The Americas/Europe -- Chapter 27. Completed Trials in China -- Chapter 28. Completed Trials in Italy -- Chapter 29. Completed Trials in Turkey -- Chapter 30. Active Trials in the United States -- Chapter 31. Active Trials in Australia -- Chapter 32. Active Trials in China -- Chapter 33. Active, Not Recruiting Trials in the US/Europe -- Chapter 34. Not Yet Recruiting Trials in China.  aThis book is a compendium of the worldwide ocular stem cell, gene therapy, optogenetic, and other miscellaneous studies treating Retinitis Pigmentosa registered with Clinicaltrials.gov. Clinicaltrials.gov is the largest website listing of registered clinical research studies in the world. The study title and the Clinical Trial Number is provided in order to make it easier for the reader to obtain further information. The book contains chapters that act as an introduction to Retinitis Pigmentosa, as well as discussion and analysis of the studies. References are also included for the readers’ use. Clinical Trials in Retinitis Pigmentosa Treatment is a valuable resource for ophthalmologists, optometrists, other physicians, and researchers. 0aOphthalmology.97207214aOphthalmology.9720722 aSpringerLink (Online service)0 tSpringer Nature eBook08iPrinted edition:z978303158798608iPrinted edition:z978303158800608iPrinted edition:z978303158801340uhttps://doi.org/10.1007/978-3-031-58799-3  aZDB-2-SME  aZDB-2-SXM  c62571d62571